{"nct_id":"NCT05925530","title":"Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2024-02-22","start_date_type":"ACTUAL","primary_completion_date":"2026-01-12","primary_completion_date_type":"ESTIMATED","completion_date":"2027-08-27","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}